Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot - ballot International flag

This page is part of the Evidence Based Medicine on FHIR Implementation Guide (v1.0.0-ballot: STU1 Ballot 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. . For a full list of available versions, see the Directory of published versions

: Remdesivir_IV_200_mg_once_then_100_mg_once_daily_for_9_days - XML Representation

Raw xml | Download



<Group xmlns="http://hl7.org/fhir">
  <id value="179783"/>
  <meta>
    <versionId value="3"/>
    <lastUpdated value="2023-12-04T20:29:22.185Z"/>
    <profile
             value="http://hl7.org/fhir/uv/ebm/StructureDefinition/exposure-definition"/>
  </meta>
  <text>
    <status value="extensions"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: Group</b><a name="179783"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Group &quot;179783&quot; Version &quot;3&quot; Updated &quot;2023-12-04 20:29:22+0000&quot; </p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-exposure-definition.html">ExposureDefinition</a></p></div><p><b>Artifact related artifact</b>: </p><p><b>Artifact Title</b>: Remdesivir IV 200 mg once then 100 mg once daily for 9 days</p><p><b>Artifact URL</b>: <a href="https://fevir.net/resources/Group/179783">https://fevir.net/resources/Group/179783</a></p><p><b>Artifact Publisher</b>: Computable Publishing LLC</p><p><b>Artifact Copyright</b>: https://creativecommons.org/licenses/by-nc-sa/4.0/</p><p><b>Artifact Contact</b>: <a href="mailto:support@computablepublishing.com">support@computablepublishing.com</a></p><p><b>Artifact Author</b>: Brian S. Alper: </p><blockquote><p><b>modifierExtension[http://hl7.org/fhir/StructureDefinition/artifact-status]</b></p></blockquote><p><b>identifier</b>: FEvIR Object Identifier: 179783</p><p><b>type</b>: animal</p><p><b>membership</b>: definitional</p><p><b>name</b>: Remdesivir_IV_200_mg_once_then_100_mg_once_daily_for_9_days</p><p><b>description</b>: Remdesivir IV 200 mg once then 100 mg once daily for 9 days</p><h3>Characteristics</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Extension</b></td><td><b>Code</b></td><td><b>Value[x]</b></td><td><b>Exclude</b></td></tr><tr><td style="display: none">*</td><td/><td>Defined by Reference <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> ()</span></td><td><a href="ActivityDefinition-213.html">ActivityDefinition/213: IV remdesivir 200 mg then 100 mg/day for 9 days</a> &quot;IV_remdesivir_200_mg_then_100_mg_day_for_9_days&quot;</td><td>false</td></tr></table></div>
  </text>
  <extension
             url="http://hl7.org/fhir/StructureDefinition/artifact-relatedArtifact">
    <valueRelatedArtifact>
      <type value="cite-as"/>
      <citation
                value="Remdesivir IV 200 mg once then 100 mg once daily for 9 days [Group]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179783. Revised 2023-11-30. Available at: https://fevir.net/resources/Group/179783. Computable resource at: https://fevir.net/resources/Group/179783."/>
    </valueRelatedArtifact>
  </extension>
  <extension url="http://hl7.org/fhir/StructureDefinition/artifact-title">
    <valueString
                 value="Remdesivir IV 200 mg once then 100 mg once daily for 9 days"/>
  </extension>
  <extension url="http://hl7.org/fhir/StructureDefinition/artifact-url">
    <valueUri value="https://fevir.net/resources/Group/179783"/>
  </extension>
  <extension
             url="http://hl7.org/fhir/StructureDefinition/artifact-publisher">
    <valueString value="Computable Publishing LLC"/>
  </extension>
  <extension
             url="http://hl7.org/fhir/StructureDefinition/artifact-copyright">
    <valueMarkdown
                   value="https://creativecommons.org/licenses/by-nc-sa/4.0/"/>
  </extension>
  <extension url="http://hl7.org/fhir/StructureDefinition/artifact-contact">
    <valueContactDetail>
      <telecom>
        <system value="email"/>
        <value value="support@computablepublishing.com"/>
      </telecom>
    </valueContactDetail>
  </extension>
  <extension url="http://hl7.org/fhir/StructureDefinition/artifact-author">
    <valueContactDetail>
      <name value="Brian S. Alper"/>
    </valueContactDetail>
  </extension>
  <modifierExtension
                     url="http://hl7.org/fhir/StructureDefinition/artifact-status">
    <valueCode value="active"/>
  </modifierExtension>
  <identifier>
    <type>
      <coding>
        <system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
        <code value="ACSN"/>
        <display value="Accession ID"/>
      </coding>
      <text value="FEvIR Object Identifier"/>
    </type>
    <system value="https://fevir.net"/>
    <value value="179783"/>
    <assigner>
      <display value="Computable Publishing LLC"/>
    </assigner>
  </identifier>
  <type value="animal"/>
  <membership value="definitional"/>
  <name value="Remdesivir_IV_200_mg_once_then_100_mg_once_daily_for_9_days"/>
  <description
               value="Remdesivir IV 200 mg once then 100 mg once daily for 9 days"/>
  <characteristic>
    <extension
               url="http://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-description">
      <valueMarkdown
                     value="Remdesivir IV 200 mg once then 100 mg once daily for 9 days"/>
    </extension>
    <code>
      <text value="Defined by Reference"/>
    </code>
    <valueReference>🔗 
      <reference value="ActivityDefinition/213"/>
      <type value="ActivityDefinition"/>
      <display value="IV remdesivir 200 mg then 100 mg/day for 9 days"/>
    </valueReference>
    <exclude value="false"/>
  </characteristic>
</Group>